Brief: Spectracure Says Study Shows Significant PSA Reduction In Prostate Cancer Patients

SpectraCure AB (publ)

04/11/2025 13:40

Nov 4 (Reuters) - SpectraCure AB (publ) SPEC.ST:

STUDY SHOWS SIGNIFICANT PSA REDUCTION IN PROSTATE CANCER PATIENTS

PSA LEVELS DROP TO 0.0-0.5 NG/ML AFTER TREATMENT

Source text: ID:nMFNx9txS

Further company coverage: SPEC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))